According to Cytokinetics 's latest financial reports the company's current EPS (TTM) is -$7.81. In 2022 the company made an earnings per share (EPS) of -$5.83 a decrease over its 2021 EPS that were of -$3.88.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$7.77 | 33.23% |
2022 | -$5.83 | 50.18% |
2021 | -$3.88 | 40.8% |
2020 | -$2.76 | -4.74% |
2019 | -$2.90 | 8.21% |
2018 | -$2.68 | -24.12% |
2017 | -$3.53 | -776.32% |
2016 | $0.52 | -139.18% |
2015 | -$1.33 | 125.58% |
2014 | -$0.59 | -67.67% |
2013 | -$1.82 | -44.58% |
2012 | -$3.29 | -44.95% |
2011 | -$5.98 | -6.84% |
2010 | -$6.42 | -290.24% |
2009 | $3.38 | -135.96% |
2008 | -$9.39 | 10.68% |
2007 | -$8.48 | -33.97% |
2006 | -$12.84 | 5.41% |
2005 | -$12.18 | -60.64% |
2004 | -$30.95 | -77.21% |
2003 | -$135.84 |